CN106727656A - A kind of antiphlogistic - Google Patents

A kind of antiphlogistic Download PDF

Info

Publication number
CN106727656A
CN106727656A CN201510798373.2A CN201510798373A CN106727656A CN 106727656 A CN106727656 A CN 106727656A CN 201510798373 A CN201510798373 A CN 201510798373A CN 106727656 A CN106727656 A CN 106727656A
Authority
CN
China
Prior art keywords
antiphlogistic
dermatitis
cefradine
lincomycin
rox
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510798373.2A
Other languages
Chinese (zh)
Inventor
薛英琦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510798373.2A priority Critical patent/CN106727656A/en
Publication of CN106727656A publication Critical patent/CN106727656A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

A kind of antiphlogistic, main formula is as follows：Ampicillin 15g, methicillin 12g, ticarcillin sodium 8g, Cefradine 4g, ROX 8g and lincomycin 10g, are well mixed, and obtain final product.Clearing heat-fire of the present invention, anti-inflammatory, antipruritic, antiallergy, hold back wound at antibacterial, evident in efficacy.

Description

A kind of antiphlogistic
Technical field
The invention belongs to externally applied drug field, it is related to a kind of antiphlogistic.
Background technology
Dermatitis and eczema are common scytitises, represent allergic reaction of the skin for a variety of materials such as chemicals, albumen, bacterium and fungi.The word of eczema one does not have special implication, and dermatitis then has the meaning of restriction.If replacing eczema as diagnosis term with dermatitis, corium, epidermis association response are referred to, it can be acute, subacute and chronic.This three can combine presence.
Dermatitis is common and multiple disease, therefore, the medicine of dermatitis is treated, indispensability substantially in family.
The content of the invention
The purpose of the present invention, is to provide a kind of antiphlogistic, and this drug effect fruit is good, and recurrence is difficult after treatment.
The technical scheme of use is：
A kind of antiphlogistic, main formula is as follows：
Ampicillin 15g, methicillin 12g, ticarcillin sodium 8g, Cefradine 4g, ROX 8g and lincomycin 10g, are well mixed, and obtain final product.
The present invention uncaps and use, and is applied to affected part, plays a part for the treatment of.
The advantage of the invention is that：
Clearing heat-fire of the present invention, anti-inflammatory, antipruritic, antiallergy, hold back wound at antibacterial, and evident in efficacy, the dermatitis in treatment caused to a variety of causes is effective.
Specific embodiment
A kind of antiphlogistic, main formula is as follows：
Ampicillin 15g, methicillin 12g, ticarcillin sodium 8g, Cefradine 4g, ROX 8g and lincomycin 10g, are well mixed, and obtain final product.

Claims (1)

1. a kind of antiphlogistic, it is characterised in that main formula is as follows：Ampicillin 15g, methicillin 12g, ticarcillin sodium 8g, Cefradine 4g, ROX 8g and lincomycin 10g, are well mixed, and obtain final product.
CN201510798373.2A 2015-11-19 2015-11-19 A kind of antiphlogistic Pending CN106727656A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510798373.2A CN106727656A (en) 2015-11-19 2015-11-19 A kind of antiphlogistic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510798373.2A CN106727656A (en) 2015-11-19 2015-11-19 A kind of antiphlogistic

Publications (1)

Publication Number Publication Date
CN106727656A true CN106727656A (en) 2017-05-31

Family

ID=58916370

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510798373.2A Pending CN106727656A (en) 2015-11-19 2015-11-19 A kind of antiphlogistic

Country Status (1)

Country Link
CN (1) CN106727656A (en)

Similar Documents

Publication Publication Date Title
CA3006294A1 (en) Combinations of rapamycin and metformin for the treatment of joint and skin diseases
WO2012026766A3 (en) Novel heterocyclic compound, and composition for treating inflammatory diseases using same
WO2013136192A3 (en) Use of tetracycline compositions for wound treatment and skin restoration
SV2011003901A (en) ARILO COMPOUNDS WITH HETEROCYCLIC SUBSTITUTES AS HIF INHIBITORS
WO2010119369A3 (en) A medicinal cream made using silver sulphadiazine and chitosan and a process to make it
BR112016013486A2 (en) ANTIMICROBIAL COMPOSITION, AND METHOD OF PRODUCTION OF AN ANTIMICROBIAL COMPOSITION
FR2972355B3 (en) ANTIMICROBIAL MIXTURE AND COATING TO ASSIST WITH HEALING, HAVING ANTIMICROBIAL EFFECT
BR112018002548A2 (en) antimicrobial composition effective against endospores
NZ754706A (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
NI201700057A (en) METHOD TO TREAT, PREVENT OR REDUCE THE RISK OF SKIN INFECTION
BR112018001002A2 (en) antimicrobial composition effective against endospores
CN106727656A (en) A kind of antiphlogistic
WO2018094023A3 (en) Cyclic dipeptides and wound healing
WO2019099860A3 (en) Wound treatment containing collagen and a gelatin-reducing agent, and method for promoting wound healing
WO2016063265A3 (en) Topical formulation for treating skin or mucosal infections, preparation method and uses thereof
CN106728264A (en) A kind of removing miliaria and relieving itching powder
WO2015100448A3 (en) Multimodal antimicrobial therapy
EA201492154A1 (en) COSMETIC AND / OR PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFLAMMATION OF THE SKIN AND RELATED SYNDROME
WO2017142368A3 (en) Composition for preventing and treating allergic or inflammatory skin disease
CN106728263A (en) A kind of removing miliaria and relieving itching powder
CN106728809A (en) A kind of Xiaoyan San
WO2016081724A3 (en) Method for the prevention and treatment of acne
WO2019009628A3 (en) Composition for relieving and treating burns and bedsores
Roos et al. The use of hypochlorous acid in an infected burn wound–a case study
MX363826B (en) Pharmaceutical composition based on centella asiatica (hydrocotyle asiatica l.) for treating lower limbs ulcers.

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170531